HeMemics Biotechnologies, Inc.
Gaithersburg
About HeMemics Biotechnologies, Inc.
Hememics Biotechnologies, Inc., a privately held biosensor company located in Gaithersburg, Maryland, is finalizing the development of a fundamentally different testing platform that can achieve near PCR-level accuracy at lateral-flow costs and is capable of testing antibodies, antigens and small molecule targets simultaneously. This platform consists of a rugged, low-cost handheld reader and a disposable biosensor that contains up to 32 pathogens using patented desiccation technology. This rapid point-of-care tool can achieve results in less than 5 minutes. The system can be wirelessly integrated with a cloud-based data analytics back end to track emerging threats dynamically. In addition to public health, this platform can also be used in defense/military and national security applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.3M
- Last round: Series Unknown (Mar 2025)
- Website: hememics.com
- Phone: 240-800-1113
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/hememics-biotechnologies-inc-44989 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.